Fecal incontinence and inflammatory bowel diseases (notice n° 1671499)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02405cam a2200241 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260301000429.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Thierry, Marie-Lise |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Fecal incontinence and inflammatory bowel diseases |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2022.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 67 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The prevalence of fecal incontinence is high in patients with inflammatory bowel disease (IBD) (between 20 and 73% depending on the study). Diarrhea, lack of colorectal reservoir, rectal compliance disorder, or sphincter rupture can cause fecal incontinence in IBD. Specific risk factors of fecal incontinence in IBD are: activity and duration of the disease, stenosing phenotype, a history of luminal surgery for IBD, pouchitis, perianal Crohn’s disease or anal stenosis, and a history of proctologic surgery. Fecal incontinence and perianal Crohn’s disease affect a patient’s quality of life: it is more difficult to access paid employment and periods of work stoppage are more frequent. Active perianal Crohn’s disease increases thirteenfold the risk of sexual dysfunction in women. Treatment of fecal incontinence is based on controlling luminal inflammation and symptomatic treatment of transit disorders. Second-line treatments for fecal incontinence such as colonic irrigations or sacral nerve stimulation are reserved for IBD patients in endoscopic remission and after failure of symptomatic treatment and anorectal rehabilitation. To prevent fecal incontinence in IBD, it is necessary to screen for perianal Crohn’s disease and to treat it early, to control rectal inflammation, to treat anoperineal fistulas with surgical drainage in combination with medical treatment, and to prefer sphincter- saving/sparing techniques to fistulotomy. The permanent stoma remains the last-resort treatment for refractory fecal incontinence to improve the patient’s quality of life. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fathallah, Nadia |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Benfredj, Paul |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Spindler, Lucas |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Abbes, Leila |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rentien, Anne-Laure |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pommaret, Élise |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | de Parades, Vincent |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Hépato-Gastro & Oncologie Digestive | 29 | 1 | 2022-01-01 | p. 56-66 | 2115-3310 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://stm.cairn.info/journal-hepato-gastro-oncologie-digestive-2022-1-page-56?lang=en&redirect-ssocas=7080">https://stm.cairn.info/journal-hepato-gastro-oncologie-digestive-2022-1-page-56?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux